With the 2025 (v 15.0) breakpoint table (for formal release on the 1st of January) EUCAST has released guidance on the reporting of susceptibility test results on endocarditis pathogens to help explain how to use the breakpoints developed for endocarditis.
Get to know moreGuidance Documents All Antibiotic Infection Methodology Pathogen Regulatory Document Title Date of Publication Previous Versions and Notes Infective endocarditis - EUCAST guidance on the reporting of antimicrobial susceptibility testing results July 2025 December 2024 Daptomycin in endocarditis and…
Get to know morePublic Consultations Public consultation is part of the EUCAST decision process. The consultation period is 4 - 12 weeks, and the dates of the beginning and end of the period is clearly stated. Current public consultations Subject Dates Description Carbapenem susceptibility testing and reporting -…
Get to know more
We’ve prepared a short video to help you get familiar with the new layout and features.